IN RE: Androgel Antitrust Litigation (No. II)

MOTION for Oral Argument re MOTION to Certify Class

N.D. Ga.June 18, 2018

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF GEORGIA ATLANTA DIVISION IN RE ANDROGEL ANTITRUST LITIGATION (NO. II) MASTER DKT. NO. 1:09-MD-2084-TWT Direct Purchaser Putative Class Actions ROCHESTER DRUG CO-OPERATIVE, INC., ET AL., Plaintiffs, v. UNIMED PHARMACEUTICALS, LLC, ET AL., Defendants. CASE NO. 1:09-CV-956-TWT LOUISIANA WHOLESALE DRUG CO., INC., ET AL., Plaintiffs, v. UNIMED PHARMACEUTICALS, LLC, ET AL., Defendants. CASE NO. 1:09-CV-957-TWT MEIJER, INC., ET AL., Plaintiffs, v. UNIMED PHARMACEUTICALS, LLC, ET AL., Defendants. CASE NO. 1:09-CV-958-TWT DEFENDANTS’ MOTION FOR ORAL ARGUMENT IN OPPOSITION TO PLAINTIFFS’ MOTION FOR CLASS CERTIFICATION Case 1:09-md-02084-TWT Document 1740 Filed 06/18/18 Page 1 of 6 2 Defendants Solvay Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc., Par Pharmaceutical Companies, Inc., and Paddock Holdings, LLC (“Defendants”) respectfully request oral argument on Direct Purchaser Putative Class Plaintiffs’ (“DPPs”) motion for class certification.1 Specifically, on February 9, 2018, the DPPs moved for class certification. On March 28, 2018, Defendants Par/Paddock filed an opposition to class certification. On April 6, 2018, Defendants Solvay and Watson also filed an opposition to class certification. On June 4, 2018, DPPs filed a reply brief. Accordingly, class certification briefing is ripe for the Court’s consideration and was submitted to chambers by the Clerk’s office on June 12, 2018. Given the complexity of this case and the various issues raised in the briefs, Defendants request oral argument. Respectfully submitted this 18th day of June 2018. /s/ Rohit K. Singla Jeffrey I. Weinberger* Rohit K. Singla* Adam R. Lawton* Joshua S. Meltzer* Justin P. Raphael* Munger, Tolles & Olson LLP 355 South Grand Avenue, 35th Floor Los Angeles, CA 90071 Teresa T. Bonder Georgia Bar No. 703969 Matthew D. Kent Georgia Bar No. 526272 Alston & Bird LLP 1201 West Peachtree Street Atlanta, GA 30309-3424 (404) 881-7000 (telephone) (404) 881-7777 (facsimile) 1 Docket No. 1652 in 1:09-md-02084-TWT; Dkt. No. 725 in 1:09-cv-00956-TWT; Dkt. No. 754 in 1:09-cv-00957-TWT; and Dkt. No. 710 in 1:09-cv-00958-TWT. Case 1:09-md-02084-TWT Document 1740 Filed 06/18/18 Page 2 of 6 3 (213) 683-9100 (telephone) (213) 687-3702 (facsimile) jeffrey.weinberger@mto.com rohit.singla@mto.com adam.lawton@mto.com joshua.meltzer@mto.com * Practicing pursuant to this Court’s Initial Case Management Order teresa.bonder@alston.com matthew.kent@alston.com Counsel for Defendant AbbVie Products LLC f/k/a Solvay Pharmaceuticals, Inc. /s/ Paul M. Eckles Steven C. Sunshine* Paul M. Eckles* Julia K. York* Timothy H. Grayson* SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP 1440 New York Ave., N.W. Washington, D.C. 20005 (202) 371-7000 (telephone) (202) 393-5760 (facsimile) steven.sunshine@skadden.com paul.eckles@skadden.com julia.york@skadden.com * Practicing pursuant to this Court’s Initial Case Management Order Benjamin J. Warlick Georgia Bar No. 594669 MORRIS, MANNING, & MARTIN LLP 3343 Peachtree Road, N.E. Suite 1600 Atlanta Financial Center Atlanta, GA 30326 (404) 233-7000 (telephone) (404) 365-9532 (facsimile) bwarlick@mmmlaw.com Counsel for Actavis, Inc. and Actavis Holdco US, Inc. /s/ Eric Grannon Eric Grannon* Adam M. Acosta* WHITE & CASE LLP 701 Thirteenth Street, N.W. Washington, D.C. 20005 Michael J. King Georgia Bar No. 421160 GREENBERG TRAURIG, LLP Terminus 200, Suite 2500 3333 Piedmont Road, N.E. Case 1:09-md-02084-TWT Document 1740 Filed 06/18/18 Page 3 of 6 4 (202) 626-3600 (telephone) (202) 639-9355 (facsimile) egrannon@whitecase.com adam.acosta@whitecase.com * Practicing pursuant to this Court’s Initial Case Management Order Atlanta, GA 30305 (678) 553-2100 (telephone) (678) 553-2212 (facsimile) kingm@gtlaw.com Counsel for Defendants Par Pharmaceutical Companies, Inc. and Paddock Holdings, LLC Case 1:09-md-02084-TWT Document 1740 Filed 06/18/18 Page 4 of 6 CERTIFICATE OF COMPLIANCE Pursuant to Local Rule 7.1(D), counsel hereby certifies that the foregoing document has been prepared in accordance with Local Rule 5.1 using Times New Roman 14-point font. Respectfully submitted this 18th day of June 2018. /s/ Adam M. Acosta Adam M. Acosta* WHITE & CASE LLP 701 Thirteenth Street, N.W. Washington, D.C. 20005 (202) 626-3600 (telephone) (202) 639-9355 (facsimile) adam.acosta@whitecase.com * Practicing pursuant to this Court’s Initial Case Management Order Counsel for Defendants Par Pharmaceutical Companies, Inc. and Paddock Holdings, LLC Case 1:09-md-02084-TWT Document 1740 Filed 06/18/18 Page 5 of 6 2 CERTIFICATE OF SERVICE Pursuant to Federal Rule of Civil Procedure 5(b) and Local Rule 5.1(A)(3), I hereby certify that a true and correct copy of DEFENDANTS’ MOTION FOR ORAL ARGUMENT IN OPPOSITION TO PLAINTIFFS’ MOTION FOR CLASS CERTIFICATION was filed with the Court’s CM/ECF system, which will automatically be distributed to counsel of record. Respectfully submitted this 18th day of June 2018. /s/ Adam M. Acosta Adam M. Acosta* WHITE & CASE LLP 701 Thirteenth Street, N.W. Washington, D.C. 20005 (202) 626-3600 (telephone) (202) 639-9355 (facsimile) adam.acosta@whitecase.com * Practicing pursuant to this Court’s Initial Case Management Order Counsel for Defendants Par Pharmaceutical Companies, Inc. and Paddock Holdings, LLC Case 1:09-md-02084-TWT Document 1740 Filed 06/18/18 Page 6 of 6